Abstract
Addiction involves complex physiological processes, and is characterised not only by broad phenotypic and behavioural traits, but also by ongoing molecular and cellular adaptations. In recent years, increasingly effective and novel techniques have been developed to unravel the molecular implications of addiction. Increasing evidence has supported a contribution of the nuclear transcription factor CREB in the development of addiction, both in contribution to phenotype and expression in brain regions critical to various aspects of drug-seeking behaviour and drug reward. Abstracting from this, models have exploited these data by removing the CREB gene from the developing or developed mouse, to crucially determine its impact upon addiction-related processes. More recent models, however, hold greater promise in unveiling the contribution of CREB to disorders such as addiction.
Keywords: CREB, conditional knockout, addiction, cAMP response element binding protein, behavior
Current Neuropharmacology
Title: The Nuclear Transcription Factor CREB: Involvement in Addiction, Deletion Models and Looking Forward
Volume: 5 Issue: 3
Author(s): Cameron S. McPherson and Andrew J. Lawrence
Affiliation:
Keywords: CREB, conditional knockout, addiction, cAMP response element binding protein, behavior
Abstract: Addiction involves complex physiological processes, and is characterised not only by broad phenotypic and behavioural traits, but also by ongoing molecular and cellular adaptations. In recent years, increasingly effective and novel techniques have been developed to unravel the molecular implications of addiction. Increasing evidence has supported a contribution of the nuclear transcription factor CREB in the development of addiction, both in contribution to phenotype and expression in brain regions critical to various aspects of drug-seeking behaviour and drug reward. Abstracting from this, models have exploited these data by removing the CREB gene from the developing or developed mouse, to crucially determine its impact upon addiction-related processes. More recent models, however, hold greater promise in unveiling the contribution of CREB to disorders such as addiction.
Export Options
About this article
Cite this article as:
McPherson S. Cameron and Lawrence J. Andrew, The Nuclear Transcription Factor CREB: Involvement in Addiction, Deletion Models and Looking Forward, Current Neuropharmacology 2007; 5 (3) . https://dx.doi.org/10.2174/157015907781695937
DOI https://dx.doi.org/10.2174/157015907781695937 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Editorial: Alcohol Hangover and the Workplace: A Need for Research
Current Drug Abuse Reviews Chronic Migraineurs Form Carboxyhemefibrinogen and Iron-Bound Fibrinogen
CNS & Neurological Disorders - Drug Targets Child and Adolescent Mental Health in the Juvenile Justice System in India: Challenges and Initiatives
Adolescent Psychiatry Laminin and its Related Peptides for the Treatment of Alzheimers Disease
Current Medicinal Chemistry - Central Nervous System Agents Paliperidone Use in the Elderly
Current Drug Safety Effect of Myricetin on the Loss of Dopaminergic Neurons in the Transgenic Drosophila Model of Parkinson’s Disease
Current Drug Therapy Molecular Biomarkers in Schizophrenia – Implications for Clinical Practice
Current Psychiatry Reviews Use and Safety of Calcium Channel Blockers in Obstetrics
Current Medicinal Chemistry Elective Cesarean Section- the Right Choice for Whom?
Current Women`s Health Reviews Management of Inflammation by Natural Polyphenols: A Comprehensive Mechanistic Update
Current Medicinal Chemistry Schizophrenia and Filicide
Current Women`s Health Reviews Meet Our Editorial Board Member
Current Computer-Aided Drug Design Statins and Alkylphospholipids as New Anticancer Agents Targeting Lipid Metabolism
Anti-Cancer Agents in Medicinal Chemistry Perception or Reality of Body Weight: Which Matters the Most to Adolescents’ Emotional Well-being?
Current Psychiatry Reviews Rationale for the Development of Cholinesterase Inhibitors as Anti- Alzheimer Agents
Current Pharmaceutical Design Design, Synthesis, and Biological Evaluation of 7H-thiazolo[3,2-b]-1,2,4-triazin-7-one Derivatives as Acetylcholinesterase Inhibitors
Letters in Drug Design & Discovery Recent Software Developments and Applications in Functional Imaging
Current Pharmaceutical Biotechnology Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets Pitavastatin and 4-Hydroxy-3-Methoxyacetophenone (HMAP) Reduce Cognitive Dysfunction in Vascular Dementia During Experimental Diabetes
Current Neurovascular Research Norwegian Children and Adolescents with ADHD - A Retrospective Clinical Study: Subtypes and Comorbid Conditions and Aspects of Cognitive Performance and Social Skills
Adolescent Psychiatry